Integral Named to Axial’s List of Top 50 Lower Middle Market Healthcare M&A Advisors

Axial is happy to release its 2024 publication of the Top 50 Lower Middle Market Healthcare Investors and M&A Advisors: a list that features Axial’s 50 most active and sought-after members who worked on transactions across various healthcare sectors over the past 12 months.

Healthcare has always undoubtedly been one of the backbones of the lower middle market. And while it may not be a standout — neither on the buyside nor the sell-side — when it comes to deals marketed and pursuit rates, the players in this industry remain strong and consistent in the middle of the pack, with 205 deals hitting the market in Q2, and an 8.17% pursuit rate (that skews significantly higher — more than double — when looking at deals $5M+ EBITDA).

Methodology

Our Top 50 healthcare list was generated based on a weighted formula leveraging four key metrics:

• The number of healthcare deals brought to market via Axial (sell-side)

• The level of interest those deals generated from Axial’s buyside member base

• The number of specific healthcare-focused investment mandates created in the platform (buyside)

• The number of healthcare deals that progressed through the deal funnel achieving a signed NDA, shared CIM, received IOI, received LOI, executed LOI or successfully consummated transaction (buyside & sell-side).

Congratulations to these members for their achievements!